Curaleaf Stock’s Parabolic Move Has Only Just Started

Curaleaf Holdings (TSXV:CURA) is, hands-down, the best way for investors to play this sector right now, for those so inclined.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The cannabis sector has moved from red hot to white hot of late. Large players such as Curaleaf Holdings (TSXV:CURA) have seen absolutely incredible share price appreciation in a relatively short amount of time.

Indeed, over the past year alone, shares of Curaleaf have nearly tripled. Here’s why I think this move is not temporary and could hold water for some time to come.

U.S. legalization the key catalyst for Curaleaf

The Biden win, coupled with a Democratic win in the U.S. senate, has once again stoked interest in the cannabis sector. Investors hopeful of federal legalization for cannabis are hanging their hats on this development.

Politically, it appears this should be a “no-brainer” to come to fruition at some point during Biden’s presidency.

If cannabis legalization materializes, this would be a huge catalyst for Curaleaf stock. That’s because Curaleaf is the largest U.S. cannabis player right now. The head-start Curaleaf has on its Canadian-listed peers is massive. Accordingly, investors looking to play the legalization trend really have one stellar option to look at.

Curaleaf’s peers are making small moves to try to get into the U.S. market without violating U.S. listing requirements and get around U.S. banking laws that don’t federally allow for lending and financial services for Canadian companies. However, these moves may be too little, too late. Curaleaf and its competitors are growing, and growing fast. Each day, market share is getting gobbled up in states like Virginia that have just legalized marijuana.

Curaleaf is in the fast lane, and its peers are the grandparents driving in the exit lane right now.

Risks prevalent, so stay diversified

On Thursday, shares of cannabis companies, as well as high-growth tech stocks, sold off dramatically. Curaleaf was no exception.

Why the selloff?

Well, rising bond yields coupled with little in the way of U.S. Federal Reserve support for bringing down longer-term yields have hurt these high-growth stocks. Indeed, it appears investors enamoured with growth right now are flipping the script toward looking at consumer discretionary, commodities, and other highly cyclical sectors. The bond market is pricing in higher inflation, and unchecked, this isn’t a good thing for growth stocks.

Additionally, there is the risk that the Senate could flip once again in 2022 if the midterm elections don’t go the Democrat’s way. Accordingly, investors shouldn’t think cannabis legalization is a done deal. It’s not. Biden will need to get a bill on the floor in the next couple years. The coronavirus pandemic is priority number one, and lower-priority items like cannabis legalization could be pushed aside.

That said, companies like Curaleaf are among the best in class right now. For those optimistic about cannabis being legalized in a relatively short amount of time, this is the best stock to pick, in my view.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Cannabis Stocks

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis (TSX:ACB) Keeps Burning Cash as Revenue Falls

Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) is still losing money. Its revenue is declining, too.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Friday, July 15

A continued selloff in metals prices is likely to pressure the commodity-heavy TSX Composite benchmark at the open today.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »